InvestorsObserver is giving Moderna Inc (MRNA) an Analyst Rating Rank of 23, meaning MRNA is ranked higher by analysts than 23% of stocks. The average price target for MRNA is $136.753 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating MRNA a Buy today. Find out what this means to you and get the rest of the rankings on MRNA!